lonidamine has been researched along with Liver Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Deng, Q; Ding, ZY; Hua, A; Li, S; Li, Z; Wan, J; Wang, C; Wang, Q; Xiong, Y; Xu, C; Yang, T; Yang, X; Zhang, BX | 1 |
| Amadori, D; De Paola, F; Frassineti, GL; Milandri, C; Ricotti, L; Tesei, A; Ulivi, P; Zoli, W | 1 |
| D'Ottavio, AM; Fabi, A; Garufi, C; Milella, M; Nisticò, C; Terzoli, E; Vaccaro, A | 1 |
| Albera, C; Gozzelino, F; Pescetti, G; Scagliotti, GV | 1 |
1 trial(s) available for lonidamine and Liver Neoplasms
| Article | Year |
|---|---|
Weekly epirubicin plus lonidamine in advanced breast carcinoma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Synergism; Epirubicin; Female; Humans; Indazoles; Injections, Intravenous; Liver Neoplasms; Middle Aged | 1999 |
3 other study(ies) available for lonidamine and Liver Neoplasms
| Article | Year |
|---|---|
A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism.
Topics: Antineoplastic Agents; Cell Line, Tumor; Glutamine; Humans; Liver Neoplasms; Mitochondria; Neoplastic Stem Cells | 2023 |
Potentiation of antiproliferative drug activity by lonidamine in hepatocellular carcinoma cells.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Cycle; Drug Interactions; Humans; Indazoles; Liver Neoplasms; Paclitaxel; Tumor Cells, Cultured | 2003 |
Chronic administration of lonidamine in untreated non-small cell lung cancer of stage III M0-1.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Indazoles; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Pyrazoles | 1989 |